Results 121 to 130 of about 696,003 (270)

A Case-Control Study on Effect of Rotavirus Monovalent G9P[11] Vaccination on the Severity of Diarrhoea in Children Aged 2-24 Months in Indonesia

open access: yesNational Journal of Community Medicine
Background: In Indonesia, rotavirus monovalent G9P[11] vaccine is the first rotavirus vaccine implemented through a government program and has never been evaluated.
Fransiskus Koda   +4 more
doaj   +1 more source

HSV-replication defective based vector as vaccines against Rotavirus infections

open access: yes, 2011
Background: Rotaviruses (RVs) are the most important cause of acute gastroenteritis in humans and animals. These viruses cause diarrheal disease primarily in the young, but infection and disease in older children and adults can occur, resulting in more ...
Facciolo, Sabrina
core  

Bovine rotavirus V1005 a P5, not a P12, type like all viruses in a German survey [PDF]

open access: yes, 1994
Bovine rotavirus (BRV) V1005, like 34 further cell culture-adapted strains in a 6-year survey in Upper Bavaria, Germany, is not a P12 but a P5 P-type rotavirus.
Sidoti, Josette   +4 more
core  

Recent Increase in Rotavirus Gastroenteritis After Five Years of Low Activity in Hokkaido Prefecture, Japan, Associated With Equine‐Like G3P[8] and G8P[8] Strains, 2025

open access: yesJournal of Medical Virology, Volume 98, Issue 5, May 2026.
ABSTRACT Rotavirus gastroenteritis decreased substantially worldwide during the COVID‐19 pandemic, and activity remained minimal in Hokkaido Prefecture, Japan, for 5 years after 2020. Hospital‐based surveillance in Hokkaido since July 2019 identified the first resurgence of rotavirus gastroenteritis in 2025.
Yuya Fukuda   +20 more
wiley   +1 more source

Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UK

open access: yesBMC Medicine, 2018
BackgroundRotavirus causes severe gastroenteritis in infants and young children worldwide. The UK introduced the monovalent rotavirus vaccine (Rotarix®) in July 2013. Vaccination is free of charge to parents, with two doses delivered at 8 and 12 weeks of
D. Hungerford   +5 more
semanticscholar   +1 more source

Diarrheal Diseases Hospitalization in Yemen before and after Rotavirus Vaccination

open access: yesScientifica, 2016
The study aims to assess the impact of rotavirus vaccine introduction on diarrheal diseases hospitalization and to identify the rotavirus genotypes most prevalent before and after vaccine introduction among children ≤ 5 years of age. Rotarix™ ® rotavirus
Mohammed Amood AL-Kamarany   +5 more
doaj   +1 more source

Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting

open access: yesBMC Medicine, 2018
Background and objective Since 2013, a biennial rotavirus pattern has emerged in the Netherlands with alternating high and low endemic years and a nearly 50% reduction in rotavirus hospitalization rates overall, while infant rotavirus vaccination has ...
P. Bruijning-Verhagen   +7 more
doaj   +1 more source

Facilitators and barriers for use of rotavirus vaccine amongst various stakeholders and its implications for Indian context – A systematic review

open access: yesHuman Vaccines & Immunotherapeutics, 2018
Background: We performed a systematic review to evaluate factors affecting uptake of rotavirus vaccine amongst physicians, parents and health system. Methods: We identified 15 studies that met the inclusion criteria from 790 screened studies published ...
Aditi Apte   +4 more
doaj   +1 more source

Impact of rotavirus vaccination on child mortality, morbidity, and rotavirus-related hospitalizations in Bolivia

open access: yesInternational Journal of Infectious Diseases, 2017
Background: The public health impact of rotavirus vaccination in countries with high child mortality rates remains to be established. The RV1 rotavirus vaccine was introduced in Bolivia in August 2008.
Lucia Inchauste   +5 more
doaj   +1 more source

Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial

open access: yesLancet. Infectious Diseases (Print), 2017
Background Efficacy of live oral rotavirus vaccines is reduced in low-income compared with high-income settings. Parenteral non-replicating rotavirus vaccines might offer benefits over oral vaccines.
M. Groome   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy